MIAMI, FL / ACCESSWIRE / August 26, 2024 / AllStar is excited to announce the signing of Enzo Concina, whose resume speaks for itself. A senior scout for a top Serie A team and previous professional soccer player for Montreal Impact and also Piacenza, Serie B.
Enzo’s duty is for pro scouting for North America and Europe and also for soccer affiliation with a top professional team in Serie C. Enzo’s experience is both in Italy and also North America, where he played professionally. We here at AllStar have a proven scout and consultant.
FOOTBALL PLAYER CAREER 1982/1994
Seasons
1994 – mid season Montreal Impact (APSL Champions “North America”)
1993/1994 AC Forli “Serie C”
1992 Unattached
1991/1992 SS Nola “Serie C”
1990/1991 SS Nola “Serie C”
1989/1990 AC Monza “Serie B”
1988/1989 Piacenza FBC “Serie B”
1987/1988 Piacenza FBC “Serie B”
1986/1987 Piacenza FBC “Serie C” (Promoted to Serie B)
1985/1986 AC Pavia “Serie C”
1984/1985 AC Pavia “Serie C”
1984 AC Cesena “Serie B”
1983/1984 US Ravenna “Serie C”
1982/1983 US Ravenna “Serie C”
1980/1982 Canadian National Under 21 (Captain)
1988/1993 Canadian Senior National Team
EDUCATION & TRAINING
AllStar Health Brands Inc.:
AllStar Health Brands Inc., founded in 2017 as a Nevada Corporation, is based in Miami, Florida. It specializes in healthcare products aimed at enhancing health and enhancing quality of life. With a focus on nutritional supplements, over-the-counter remedies, and medications, AllStar serves markets in North America and Europe. The company is committed to expanding its product offerings, introducing innovative solutions for improved human health, and fostering growth through acquisitions, mergers, and collaborations.
For more information please contact:
Peter Wanner, CEO AllStarHealth Brands, Inc (ALST)
Tel: 416.918.6987
email: peterw@allstarhealthbrands.com
SOURCE: AllStar Health Brands, Inc.
View the original press release on accesswire.com
NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in…
DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or…
Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New…
Diarrhea is one of the most common reasons for veterinary visits for dogs and the…
Developing innovative bispecific antibodies for monotherapy and combination with the potential to expand the frontiers…
FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the…